• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在肠易激综合征中,结肠黏膜活检部位不会影响黏膜代谢组学和黏膜微生物群分析的结果。

Colonic mucosal biopsy location can not affect the results of mucosal metabolomics and mucosal microbiota analysis in IBS.

作者信息

Zhu Huiting, Zhang Yanli, Du Shiyu, Wang Huifen, Zheng Yue

机构信息

Department of Internal Medicine, Hebei Medical University, Shijiazhuang, China.

Department of Gastroenterology, First Hospital of Qinhuangdao, Qinhuangdao, China.

出版信息

Front Med (Lausanne). 2023 Jun 7;10:1183484. doi: 10.3389/fmed.2023.1183484. eCollection 2023.

DOI:10.3389/fmed.2023.1183484
PMID:37351069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10282601/
Abstract

OBJECTIVE

To compare and analyze the mucosal metabolites and mucosal microbiota of different parts of colon in patients with IBS.

METHODS

A total of 10 patients with IBS-D and six healthy controls (HC) were enrolled. All enrolled participants underwent two biopsies of the ileocecal and sigmoid colon during colonoscopy. Metabolomic profiling of one piece of tissue was conducted using desorption electrospray ionization-mass spectrometry (DESI-MS), and the gut flora of the other piece was examined using 16S rRNA sequencing. The metabolic profiles and flora of the ileocecal and sigmoid colonic mucosa in each group were further analyzed in this study.

RESULTS

(1) Principal components analysis (PCA) indicated that mucosal metabolites did not differ in different parts of the colon in either the IBS-D or HC groups. (2) In the mucosal microbiome analyses, no differences between the microbiota of the two parts of the colon were found by using Principal Co-ordinates Analysis (PCoA). In IBS group, comparing with sigmoid mucosa, the chao1 richness indice was higher and the Shannon index was lower in the ileocecal mucosa ( = 0.40,  = 0.22). However, in the HC group, microbiome analysis of the ileocecal mucosa showed lower values for Chao 1 and Shannon indices than those of the sigmoid colon mucosa ( = 0.06,  = 0.86). (3) Compared with the HC group, 1,113 metabolic signal peaks were upregulated, whereas 594 metabolites were downregulated in the IBS-D samples. Moreover, the PCA of the metabolites showed significant separation between the IBS-D and HC groups. (4) Chao1 expression was significantly higher in the mucosal microbiota with IBS-D than in the HC ( = 0.03). The Shannon index was lower in IBS-D, but the difference was not statistically significant ( = 0.53). PCoA revealed a significant difference in the microflora structure between the IBS-D and HC groups.

CONCLUSION

The mucosal metabolic profile and mucosal flora structure of the colon were similar, despite different locations in IBS and healthy subjects. IBS had abnormal colonic mucosal metabolism and flora disturbances.

摘要

目的

比较和分析肠易激综合征(IBS)患者结肠不同部位的黏膜代谢物和黏膜微生物群。

方法

共纳入10例腹泻型肠易激综合征(IBS-D)患者和6名健康对照者(HC)。所有纳入的参与者在结肠镜检查期间对回盲部和乙状结肠进行了两次活检。使用解吸电喷雾电离质谱(DESI-MS)对其中一块组织进行代谢组分析,另一块组织的肠道菌群则采用16S rRNA测序进行检测。本研究进一步分析了每组回盲部和乙状结肠黏膜的代谢谱和菌群情况。

结果

(1)主成分分析(PCA)表明,IBS-D组和HC组结肠不同部位的黏膜代谢物无差异。(2)在黏膜微生物组分析中,通过主坐标分析(PCoA)未发现结肠两个部位的微生物群存在差异。在IBS组中,与乙状结肠黏膜相比,回盲部黏膜的chao1丰富度指数较高,而香农指数较低(P = 0.40,P = 0.22)。然而,在HC组中,回盲部黏膜的微生物组分析显示Chao 1和香农指数的值低于乙状结肠黏膜(P = 0.06,P = 0.86)。(3)与HC组相比,IBS-D样本中有1113个代谢信号峰上调,而594种代谢物下调。此外,代谢物的PCA显示IBS-D组和HC组之间有明显分离。(4)IBS-D患者黏膜微生物群中的Chao1表达明显高于HC组(P = 0.03)。IBS-D组的香农指数较低,但差异无统计学意义(P = 0.53)。PCoA显示IBS-D组和HC组之间的微生物群结构存在显著差异。

结论

尽管IBS患者和健康受试者结肠的位置不同,但其结肠黏膜代谢谱和黏膜菌群结构相似。IBS存在结肠黏膜代谢异常和菌群紊乱。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbf8/10282601/ebc7e788e08d/fmed-10-1183484-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbf8/10282601/ebc7e788e08d/fmed-10-1183484-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbf8/10282601/ebc7e788e08d/fmed-10-1183484-g002.jpg

相似文献

1
Colonic mucosal biopsy location can not affect the results of mucosal metabolomics and mucosal microbiota analysis in IBS.在肠易激综合征中,结肠黏膜活检部位不会影响黏膜代谢组学和黏膜微生物群分析的结果。
Front Med (Lausanne). 2023 Jun 7;10:1183484. doi: 10.3389/fmed.2023.1183484. eCollection 2023.
2
Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.腹泻型肠易激综合征患者的粪便和黏膜相关肠道微生物群。
Dig Dis Sci. 2018 Jul;63(7):1890-1899. doi: 10.1007/s10620-018-5086-4. Epub 2018 May 17.
3
Mucosa-Associated Microbiota in Patients with Irritable Bowel Syndrome: A Comparison of Subtypes.肠易激综合征患者的黏膜相关微生物群:亚型比较。
Digestion. 2021;102(1):49-56. doi: 10.1159/000512167. Epub 2020 Dec 3.
4
[Associations of sigmoid colon mucosal mast cells with bowel symptoms and psychological status in patients with irritable bowel syndrome with diarrhea].腹泻型肠易激综合征患者乙状结肠黏膜肥大细胞与肠道症状及心理状态的相关性
Zhonghua Yi Xue Za Zhi. 2016 Aug 9;96(30):2398-403. doi: 10.3760/cma.j.issn.0376-2491.2016.30.007.
5
The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects.肠易激综合征患者与健康受试者粪便相关微生物群和黏膜相关微生物群之间的关系。
Aliment Pharmacol Ther. 2015 Nov;42(10):1211-21. doi: 10.1111/apt.13399. Epub 2015 Sep 17.
6
Sex Differences in Colonic Mucosal Microbiome of Irritable Bowel Syndrome Patients Compared to Healthy Controls.与健康对照相比,肠易激综合征患者结肠黏膜微生物群的性别差异
medRxiv. 2024 Aug 2:2024.07.31.24311317. doi: 10.1101/2024.07.31.24311317.
7
Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome.共享黏膜相关微生物群在腹泻为主的肠易激综合征的十二指肠和直肠中的作用。
J Gastroenterol Hepatol. 2018 Jun;33(6):1220-1226. doi: 10.1111/jgh.14059. Epub 2018 Feb 26.
8
Involvement of mucosal flora and enterochromaffin cells of the caecum and descending colon in diarrhoea-predominant irritable bowel syndrome.回盲部和降结肠的黏膜菌群和肠嗜铬细胞参与腹泻为主的肠易激综合征。
BMC Microbiol. 2021 Nov 13;21(1):316. doi: 10.1186/s12866-021-02380-2.
9
Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome.腹泻型肠易激综合征患者的腔内和黏膜相关肠道微生物组的分子分析。
Am J Physiol Gastrointest Liver Physiol. 2011 Nov;301(5):G799-807. doi: 10.1152/ajpgi.00154.2011. Epub 2011 Jul 7.
10
[Comparison of gut microbiotal compositional analysis of patients with irritable bowel syndrome through different bioinformatics pipelines].[通过不同生物信息学流程对肠易激综合征患者肠道微生物群组成分析的比较]
Beijing Da Xue Xue Bao Yi Xue Ban. 2018 Apr 18;50(2):231-238.

引用本文的文献

1
Multifluid Metabolomics Identifies Novel Biomarkers for Irritable Bowel Syndrome.多流体代谢组学鉴定肠易激综合征的新型生物标志物。
Metabolites. 2025 Feb 12;15(2):121. doi: 10.3390/metabo15020121.
2
Gut microbial dysbiosis associated to diarrheic irritable bowel syndrome can be efficiently simulated in the Mucosal ARtificial COLon (M-ARCOL).与腹泻型肠易激综合征相关的肠道微生物失调可以在黏膜人工结肠(M-ARCOL)中得到有效模拟。
Bioengineered. 2025 Dec;16(1):2458362. doi: 10.1080/21655979.2025.2458362. Epub 2025 Feb 4.

本文引用的文献

1
Serum Lipidomic Screen Identifies Key Metabolites, Pathways, and Disease Classifiers in Crohn's Disease.血清脂质组学筛查鉴定克罗恩病的关键代谢物、途径和疾病分类器。
Inflamm Bowel Dis. 2023 Jul 5;29(7):1024-1037. doi: 10.1093/ibd/izac281.
2
Understanding of the Site-Specific Microbial Patterns towards Accurate Identification for Patients with Diarrhea-Predominant Irritable Bowel Syndrome.了解腹泻型肠易激综合征患者的特定部位微生物模式,以进行准确的识别。
Microbiol Spectr. 2021 Dec 22;9(3):e0125521. doi: 10.1128/Spectrum.01255-21.
3
Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome.
肠菌代谢物与肠易激综合征
Front Cell Infect Microbiol. 2021 Sep 23;11:729346. doi: 10.3389/fcimb.2021.729346. eCollection 2021.
4
Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier.肠道上皮屏障的炎症与微生物群相关调节
Front Nutr. 2021 Sep 13;8:718356. doi: 10.3389/fnut.2021.718356. eCollection 2021.
5
Metabolic Profiling of Plasma in Patients with Irritable Bowel Syndrome after a 4-Week Starch- and Sucrose-Reduced Diet.肠易激综合征患者在进行为期4周的低淀粉和蔗糖饮食后血浆的代谢谱分析。
Metabolites. 2021 Jul 4;11(7):440. doi: 10.3390/metabo11070440.
6
Alterations in short-chain fatty acids and serotonin in irritable bowel syndrome: a systematic review and meta-analysis.肠易激综合征中短链脂肪酸和血清素的变化:系统评价和荟萃分析。
BMC Gastroenterol. 2021 Jan 6;21(1):14. doi: 10.1186/s12876-020-01577-5.
7
Epidemiologic Burden and Treatment of Chronic Symptomatic Functional Bowel Disorders in the United States: A Nationwide Analysis.美国慢性症状性功能性肠病的流行病学负担和治疗:一项全国性分析。
Gastroenterology. 2021 Jan;160(1):88-98.e4. doi: 10.1053/j.gastro.2020.09.041. Epub 2020 Oct 1.
8
Longitudinal Multi-omics Reveals Subset-Specific Mechanisms Underlying Irritable Bowel Syndrome.纵向多组学揭示了肠易激综合征的亚型特异性发病机制。
Cell. 2020 Sep 17;182(6):1460-1473.e17. doi: 10.1016/j.cell.2020.08.007. Epub 2020 Sep 10.
9
Mucosal Microbiome Profiles Polygenic Irritable Bowel Syndrome in Mestizo Individuals.黏膜微生物组特征可预测梅斯蒂索人多发肠易激综合征。
Front Cell Infect Microbiol. 2020 Mar 20;10:72. doi: 10.3389/fcimb.2020.00072. eCollection 2020.
10
No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population.在瑞典随机人群中未发现肠易激综合征的独特微生物组特征。
Gut. 2020 Jun;69(6):1076-1084. doi: 10.1136/gutjnl-2019-318717. Epub 2019 Oct 10.